FDA Inspection
Bristol-Myers Squibb Holdings Pharma Ltd. Liability CompanyBristol-Myers Squibb Holdings Pharma Ltd. Liability Company – FDA Inspection, Feb 6, 2019
Record Details
This FDA Inspection record concerns Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company, with an inspection on February 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 6, 2019
- Product Type
- Drugs
View Company Profile
ID · 723ebad3-1d56-4593-b123-69622c15f890
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1079769
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
13| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | San Juan District Office | |
| June 6, 2024 | Not classified | San Juan District Office | |
| July 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 19, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.